Nature Microbiology · 2024 · 76 citations · 80 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityComparative ImmunologyInnate ImmunityAntiviral ImmunityInnate Immune ReceptorsInnate Immune RecognitionInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesAntiviral Innate SignalingImmune Escape EvolutionInnate Immune AntagonismInnate Immune ControlInnate Immunity PathwaysSars-cov-2 InfectionViral Spike ProteinsVirus Genotypes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) human adaptation resulted in distinct lineages with enhanced transmissibility called variants of concern (VOCs). Omicron is the first VOC to evolve distinct globally dominant subvariants. Here we compared their replication in human cell lines and primary airway cultures and measured host responses to infection. We discovered that subvariants BA.4 and BA.5 have improved their suppression of innate immunity when compared with earlier subvariants BA.1 and BA.2. Similarly, more recent subvariants (BA.2.75 and XBB lineages) also triggered reduced innate immune activation. This correlated with increased expression of viral innate antagonists Orf6 and nucleocapsid, reminiscent of VOCs Alpha to Delta. Increased Orf6 levels suppressed host innate responses to infection by decreasing IRF3 and STAT1 signalling measured by transcription factor phosphorylation and nuclear translocation. Our data suggest that convergent evolution of enhanced innate immune antagonist expression is a common pathway of human adaptation and link Omicron subvariant dominance to improved innate immune evasion.
80
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung‐Min Oh, Christopher C. Venters, Chao Di et al. · Nature Communications · 2020 · 7.2K citations · Full text
Nextstrain: real-time tracking of pathogen evolution
James Hadfield, Colin Megill, Sidney M. Bell et al. · Bioinformatics · 2018 · 3.4K citations · Full text
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text